Sartorius acquires majority stake in CellGenix

Portfolio expanded by cell culture components, such as growth factors, cytokines, and media

05-Jul-2021 - The life science group Sartorius, through its subgroup Sartorius Stedim Biotech, has acquired a majority stake in the reagent manufacturer CellGenix GmbH. The company based in Freiburg, Germany, and with a sales subsidiary near the biotechnology hub in Boston, Massachusetts USA, produces and ...

Microreactor for synthesis with Grignard reagents

Continuous process control: faster, safer, cleaner

06-Jan-2021 - In 1912, Victor Grignard was awarded the Nobel Prize in Chemistry for his discovery of what came to be known as Grignard reagents. Since then, these compounds have come to play a key role in the chemical and pharmaceutical industries. Now, in a development by Fraunhofer researchers, a new type of ...

Successful exit – Proteintech acquires ChromoTek

The acquisition enables Proteintech to expand its next-generation antibody tools

21-Oct-2020 - High-Tech Gründerfonds and Bayern Kapital have sold their shares in ChromoTek after having spent 10 years at the start-up’s side. ChromoTek is the market leader in nanobodies — high-performance recombinant reagents that are used for breakthrough research discoveries. The combined companies will ...

Innovative technology for the enrichment of free-circulating DNA

13-Jan-2014 - After a two year period of development Analytik Jena has launched an innovative technology to enrich and isolate free-circulating DNA. Free-circulating DNA occurs in plasma, serum, and urine, among other things, but only in small fragments and very low concentrations. In order to isolate them, ...

celares GmbH brings GMP-production facility into operation

11-Oct-2010 - The Berlin drug delivery company celares GmbH has brought a GMP production facility for the synthesis of activated PEG-reagents into operation in September. The company now belongs to a handful of worldwide suppliers that is capable of producing these special reagents in the required quality for ...

High-sensitivity protein analysis: Biosensor chip recognizes diseases

26-Apr-2010 - In the battle against cancer and other diseases, precise analysis of specific proteins can point the way toward targeted treatments. Scientists at the Technische Universitaet Muenchen (TUM), together with Fujitsu Laboratories of Japan, have developed a novel biosensor chip that not only ...

Cooperation between NorDiag and Molzym

19-Feb-2010 - NorDiag and Molzym have now succeeded to combine their respective technologies into an integrated system for automated molecular detection of pathogens, among others for sepsis testing. Following this milestone, the two companies have signed a firm collaboration agreement regarding sale of an ...